{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:15:36Z","timestamp":1788315336155,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"DOI":"10.1007\/s00467-026-07531-z","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:36:08Z","timestamp":1788312968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Corticosteroids in childhood IgA vasculitis: can early therapy mask kidney involvement?"],"prefix":"10.1007","author":[{"given":"Alexandra","family":"Cambier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel","family":"Delbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-1359","authenticated-orcid":false,"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"7531_CR1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM et al (2010) EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798\u2013806. https:\/\/doi.org\/10.1136\/ard.2009.116657","journal-title":"Ann Rheum Dis"},{"key":"7531_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/18756336MTA2lNDYc2","volume":"16","author":"AKC Leung","year":"2020","unstructured":"Leung AKC, Barankin B, Leong KF (2020) Henoch-Schonlein purpura in children: an updated review. Curr Pediatr Rev 16:265\u2013276","journal-title":"Curr Pediatr Rev"},{"key":"7531_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/adc.2009.167874","volume":"95","author":"O Jauhola","year":"2010","unstructured":"Jauhola O, Ronkainen J, Koskimies O et al (2010) Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. Arch Dis Child 95:871\u2013876. https:\/\/doi.org\/10.1136\/adc.2009.167874","journal-title":"Arch Dis Child"},{"key":"7531_CR4","doi-asserted-by":"publisher","unstructured":"Shi D, Chan H, Yang X et al (2019) Risk factors associated with IgA vasculitis with nephritis (Henoch-Sch\u00f6nlein purpura nephritis) progressing to unfavorable outcomes: a meta-analysis. PLoS One 14:e0223218. https:\/\/doi.org\/10.1371\/journal.pone.0223218","DOI":"10.1371\/journal.pone.0223218"},{"key":"7531_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/apa.12723","volume":"104","author":"E Tudorache","year":"2015","unstructured":"Tudorache E, Azema C, Hogan J et al (2015) Even mild cases of paediatric Henoch-Sch\u00f6nlein purpura nephritis show significant long-term proteinuria. Acta Paediatr 104:843\u2013848. https:\/\/doi.org\/10.1111\/apa.12723","journal-title":"Acta Paediatr"},{"key":"7531_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-024-06502-6","volume":"40","author":"M Vivarelli","year":"2025","unstructured":"Vivarelli M, Samuel S, Coppo R et al (2025) IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol 40:533\u2013569","journal-title":"Pediatr Nephrol"},{"key":"7531_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112310","volume":"10","author":"E Pillebout","year":"2021","unstructured":"Pillebout E (2021) IgA vasculitis and IgA nephropathy: same disease? J Clin Med 10:2310. https:\/\/doi.org\/10.3390\/jcm10112310","journal-title":"J Clin Med"},{"key":"7531_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12519-014-0534-5","volume":"11","author":"JY Chen","year":"2025","unstructured":"Chen JY, Mao JH (2025) Henoch-Sch\u00f6nlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr 11:29\u201334. https:\/\/doi.org\/10.1007\/s12519-014-0534-5","journal-title":"World J Pediatr"},{"key":"7531_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ki.2011.16","volume":"80","author":"K Kiryluk","year":"2011","unstructured":"Kiryluk K, Moldoveanu Z, Sanders JT et al (2011) Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis. Kidney Int 80:79\u201387. https:\/\/doi.org\/10.1038\/ki.2011.16","journal-title":"Kidney Int"},{"key":"7531_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2215\/CJN.0000000000000398","volume":"19","author":"SJ Barbour","year":"2024","unstructured":"Barbour SJ, Coppo R, Er L et al (2024) Histologic and clinical factors associated with kidney outcomes in IgA vasculitis nephritis. Clin J Am Soc Nephrol 19:438\u2013451","journal-title":"Clin J Am Soc Nephrol"},{"key":"7531_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00467-023-06121-7","volume":"39","author":"A Cambier","year":"2024","unstructured":"Cambier A, Roy JP, Dossier C et al (2024) IgA nephropathy in children with minimal proteinuria: to biopsy or not to biopsy? Pediatr Nephrol 39:781\u2013787","journal-title":"Pediatr Nephrol"},{"key":"7531_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/adc.2005.074641","volume":"90","author":"H Narchi","year":"2005","unstructured":"Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916\u2013920. https:\/\/doi.org\/10.1136\/adc.2005.074641","journal-title":"Arch Dis Child"},{"key":"7531_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1159\/000501459","volume":"44","author":"J Tan","year":"2019","unstructured":"Tan J, Tang Y, Xu Y et al (2019) The clinicopathological characteristics of Henoch-Schonlein purpura nephritis with presentation of nephrotic syndrome. Kidney Blood Press Res 44:754\u2013764. https:\/\/doi.org\/10.1159\/000501459","journal-title":"Kidney Blood Press Res"},{"key":"7531_CR14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/art.1780330809","volume":"33","author":"JA Mills","year":"1990","unstructured":"Mills JA, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 33:1114\u20131121. https:\/\/doi.org\/10.1002\/art.1780330809","journal-title":"Arthritis Rheum"},{"key":"7531_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/MNH.0000000000000972","volume":"33","author":"M Haas","year":"2024","unstructured":"Haas M (2024) IgA vasculitis nephritis: insights from kidney biopsies. Curr Opin Nephrol Hypertens 33:298\u2013303","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"7531_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1542\/peds.2007-0667","volume":"120","author":"PF Weiss","year":"2007","unstructured":"Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C (2007) Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics 120:1079\u20131087","journal-title":"Pediatrics"},{"key":"7531_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","volume":"149","author":"J Ronkainen","year":"2006","unstructured":"Ronkainen J, Koskimies O, Ala-Houhala M et al (2006) Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241\u2013247","journal-title":"J Pediatr"},{"key":"7531_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-2-7","volume":"2","author":"AM Huber","year":"2004","unstructured":"Huber AM, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura [ISRCTN85109383]. BMC Med 2:7","journal-title":"BMC Med"},{"issue":"2","key":"7531_CR19","doi-asserted-by":"publisher","first-page":"CD005128","DOI":"10.1002\/14651858.CD005128.pub4","volume":"2","author":"D Hahn","year":"2023","unstructured":"Hahn D, Hodson EM, Craig JC (2023) Interventions for preventing and treating kidney disease in IgA vasculitis. Cochrane Database Syst Rev 2:CD005128","journal-title":"Cochrane Database Syst Rev"},{"key":"7531_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","volume":"98","author":"J Dudley","year":"2013","unstructured":"Dudley J, Smith G, Llewelyn-Edwards A, Bayliss K, Pike K, Tizard J (2013) Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP). Arch Dis Child 98:756\u2013763. https:\/\/doi.org\/10.1136\/archdischild-2013-303642","journal-title":"Arch Dis Child"},{"key":"7531_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00467-012-2106-z","volume":"27","author":"O Jauhola","year":"2012","unstructured":"Jauhola O, Ronkainen J, Koskimies O et al (2012) Outcome of Henoch-Schonlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatr Nephrol 27:933\u2013939. https:\/\/doi.org\/10.1007\/s00467-012-2106-z","journal-title":"Pediatr Nephrol"},{"issue":"4S","key":"7531_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2025.04.004","volume":"108","author":"BH Rovin","year":"2025","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group, Rovin BH et al (2025) KDIGO 2025 clinical practice guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV). Kidney Int 108(4S):S1\u2013S71. https:\/\/doi.org\/10.1016\/j.kint.2025.04.004","journal-title":"Kidney Int"},{"key":"7531_CR23","doi-asserted-by":"publisher","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2015) Interventions for preventing and treating kidney disease in Henoch-Schonlein Purpura (HSP). Cochrane Database Syst Rev (8):CD005128. https:\/\/doi.org\/10.1002\/14651858.CD005128.pub3","DOI":"10.1002\/14651858.CD005128.pub3"},{"key":"7531_CR24","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/ndt\/gfae009","volume":"39","author":"K Rohner","year":"2024","unstructured":"Rohner K, Marlais M, Ahn YH et al (2024) Outcome of immunosuppression in children with IgA vasculitis-related nephritis. Nephrol Dial Transplant 39:1299\u20131309","journal-title":"Nephrol Dial Transplant"},{"key":"7531_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-026-07491-4","author":"DH Kim","year":"2026","unstructured":"Kim DH, Lee JH, Park JS, Lee JY, Choi SJ, Lee JS, Jung J (2026) Patterns of kidney involvement after corticosteroid treatment for extrarenal symptoms in pediatric IgA vasculitis (Henoch-Sch\u00f6nlein Purpura): phenotypes and outcomes. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-026-07491-4","journal-title":"Pediatr Nephrol"},{"key":"7531_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/adc.2005.074641","volume":"90","author":"H Narchi","year":"2005","unstructured":"Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916\u2013920","journal-title":"Arch Dis Child"},{"key":"7531_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.kint.2021.09.023","volume":"101","author":"A Cambier","year":"2022","unstructured":"Cambier A, Gleeson PJ, Abbad L et al (2022) Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy. Kidney Int 101:274\u2013287. https:\/\/doi.org\/10.1016\/j.kint.2021.09.023","journal-title":"Kidney Int"},{"key":"7531_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-026-07382-8","author":"MA Beldie","year":"2026","unstructured":"Beldie MA, Hernadfoi MV, Fazekas KK et al (2026) Biomarkers of kidney involvement in paediatric IgA vasculitis: a systematic review and meta-analysis. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-026-07382-8","journal-title":"Pediatr Nephrol"},{"key":"7531_CR29","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1007\/s10067-023-06781-8","volume":"42","author":"CEC Williams","year":"2023","unstructured":"Williams CEC, Lamond M, Marro J, Chetwynd AJ, Oni L (2023) A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP). Clin Rheumatol 42:3189\u20133200","journal-title":"Clin Rheumatol"},{"key":"7531_CR30","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00281-021-00874-9","volume":"43","author":"E Pillebout","year":"2021","unstructured":"Pillebout E, Sunderkotter C (2021) IgA vasculitis. Semin Immunopathol 43:729\u2013738. https:\/\/doi.org\/10.1007\/s00281-021-00874-9","journal-title":"Semin Immunopathol"},{"key":"7531_CR31","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s00467-025-07004-9","volume":"41","author":"A Cambier","year":"2026","unstructured":"Cambier A, Lachize Neanne L, Sahu S, Arbez L, Maillard N (2026) IgA nephropathy new therapies: from data in adults to application in children. Pediatr Nephrol 41:1921\u20131935. https:\/\/doi.org\/10.1007\/s00467-025-07004-9","journal-title":"Pediatr Nephrol"},{"key":"7531_CR32","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000001172","author":"A Cambier","year":"2026","unstructured":"Cambier A, Lachize-Neanne L, Haas M (2026) IgA nephropathy across the age spectrum: urgent need to accelerate pediatric access to therapeutic innovation. Clin J Am Soc Nephrol. https:\/\/doi.org\/10.2215\/CJN.0000001172","journal-title":"Clin J Am Soc Nephrol"},{"key":"7531_CR33","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.3390\/jcm13216621","volume":"13","author":"S Castaneda","year":"2024","unstructured":"Castaneda S, Quiroga-Colina P, Floranes P et al (2024) IgA vasculitis (Henoch-Schonlein Purpura): an update on treatment. J Clin Med 13:6621. https:\/\/doi.org\/10.3390\/jcm13216621","journal-title":"J Clin Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07531-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07531-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07531-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:36:10Z","timestamp":1788312970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07531-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":33,"alternative-id":["7531"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07531-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"6 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}